Skip to main content
PMC home page
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 1985 Jul;50(1):63–67. doi: 10.1128/aem.50.1.63-67.1985

Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.

C Shone, P Wilton-Smith, N Appleton, P Hambleton, N Modi, S Gatley, J Melling
PMCID: PMC238574  PMID: 3927840

Abstract

A monoclonal antibody (BA11) has been produced against Clostridium botulinum type A neurotoxin by the fusion of myeloma cells (P3 NS1/1-Ag4-1) with spleen cells from BALB/c mice immunized with botulinum type A neurotoxoid. The antibody bound specifically to botulinum type A neurotoxin, showing no cross-reactivity with types B and E botulinum toxins or with any of several other bacterial toxins tested. The monoclonal antibody did not bind to botulinum type A neurotoxin which had been denatured with sodium dodecyl sulfate and bound only weakly to each of the separated heavy and light subunits of the neurotoxin, suggesting a conformational requirement for the antigenic determinant of the antibody. A sensitive immunoassay for C. botulinum type A toxin with monoclonal antibody BA11 in conjunction with an enzyme amplication system has been developed which allows detection of 5 to 10 mouse 50% lethal doses ml-1 of purified neurotoxin. The assay was equally sensitive when applied to the detection of crude toxin in food stuffs; the average value for the minimum level of detectable toxin in extracts of tinned salmon or corned beef was 9 +/- 3.1 mouse 50% lethal doses ml-1.

Full text

PDF
63

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DUFF J. T., WRIGHT G. G., KLERER J., MOORE D. E., BIBLER R. H. Studies on immunity to toxins of Clostridium botulinum. I. A simplified procedure for isolation of type A toxin. J Bacteriol. 1957 Jan;73(1):42–47. doi: 10.1128/jb.73.1.42-47.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dezfulian M., Bartlett J. G. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals. J Clin Microbiol. 1984 May;19(5):645–648. doi: 10.1128/jcm.19.5.645-648.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ellens D. J., Gielkens A. L. A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA). J Immunol Methods. 1980;37(3-4):325–332. doi: 10.1016/0022-1759(80)90318-x. [DOI] [PubMed] [Google Scholar]
  4. Ey P. L., Prowse S. J., Jenkin C. R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978 Jul;15(7):429–436. doi: 10.1016/0161-5890(78)90070-6. [DOI] [PubMed] [Google Scholar]
  5. Irons L. I., Ashworth L. A., Wilton-Smith P. Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies. J Gen Microbiol. 1983 Sep;129(9):2769–2778. doi: 10.1099/00221287-129-9-2769. [DOI] [PubMed] [Google Scholar]
  6. Kozaki S., Dufrenne J., Hagenaars A. M., Notermans S. Enzyme linked immunosorbent assay (ELISA) for detection of Clostridium botulinum type B toxin. Jpn J Med Sci Biol. 1979 Aug;32(4):199–205. doi: 10.7883/yoken1952.32.199. [DOI] [PubMed] [Google Scholar]
  7. Moberg L. J., Sugiyama H. Affinity chromatography purification of type A botulinum neurotoxin from crystalline toxic complex. Appl Environ Microbiol. 1978 May;35(5):878–880. doi: 10.1128/aem.35.5.878-880.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Notermans S., Dufrenne J., Kozaki S. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin. Appl Environ Microbiol. 1979 Jun;37(6):1173–1175. doi: 10.1128/aem.37.6.1173-1175.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Notermans S., Dufrenne J., Schothorst M. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A. Jpn J Med Sci Biol. 1978 Feb;31(1):81–85. doi: 10.7883/yoken1952.31.81. [DOI] [PubMed] [Google Scholar]
  10. Notermans S., Hagenaars A. M., Kozaki S. The enzyme-linked immunosorbent assay (ELISA) for the detection and determination of Clostridium botulinum toxins A, B, and E. Methods Enzymol. 1982;84:223–238. doi: 10.1016/0076-6879(82)84020-2. [DOI] [PubMed] [Google Scholar]
  11. Simpson L. L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev. 1981 Sep;33(3):155–188. [PubMed] [Google Scholar]
  12. Sugiyama H. Clostridium botulinum neurotoxin. Microbiol Rev. 1980 Sep;44(3):419–448. doi: 10.1128/mr.44.3.419-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tse C. K., Dolly J. O., Hambleton P., Wray D., Melling J. Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur J Biochem. 1982 Mar 1;122(3):493–500. [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES